FDA.reportPublic FDA data

FILSPARI 200 MG Oral Tablet

RxCUI
2630546
RxNorm name
FILSPARI 200 MG Oral Tablet
Display name
FILSPARI 200 MG Oral Tablet
Full name
FILSPARI 200 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FILSPARISPARSENTANTravere Therapeutics, Inc.d7354af1-f304-f4d9-e053-2995a90ab2192026-04-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2630546

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d7354af1-f304-f4d9-e053-2995a90ab219FILSPARI 200 MG Oral Tablet [PSN] · sparsentan 200 MG Oral Tablet [Filspari] [SBD] · Filspari 200 MG Oral Tablet [SY]37These highlights do not include all the information needed to use FILSPARI ® safely and effectively. See full prescribing information for FILSPARI ® . FILSPARI ® (sparsentan) tablets, for oral use Initial U.S. Approval: 202320260409